---
title: "Anti-CD19/20/22 Chimeric Antigen Receptor T Cells (TriCAR19.20.22 T Cells) for the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, and Chronic Lymphocytic Leukemia"
date: "2025-09-10T04:00:00.000Z"
publishedDate: "10 septembre 2025"
summary: "Conditions : Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive; Recurrent Acute Lymphoblastic Leukemia; Recurrent Chronic Lymphocytic Leukemia; Recurrent Chronic Myeloid Leukemia, BCR-ABL1 Positive; Recurrent Indolent Non-Hodgkin Lymphoma; Recurrent Lymphoblastic Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Transformed Chronic Lymphocytic Leukemia; Refractory Acute Lymphoblastic Leukemia; Refractory Chronic Lymphocytic Leukemia; Refractory Chronic Myeloid Leukemia, BCR-ABL1 Positive; Refractory Indolent Non-Hodgkin Lymphoma; Refractory Lymphoblastic Lymphoma; Refractory Non-Hodgkin Lymphoma; Refractory Transformed Chronic Lymphocytic Leukemia Interventions : Biological: Autologous Anti-CD19/CD20/CD22 CAR T-cells; Procedure: Biospecimen Collection; Procedure: Bone Marrow Aspiration; Procedure: Bone Marrow Biopsy; Procedure: Computed Tomography; Drug: Cyclophosphamide; Procedure: Echocardiography Test; Drug: Fludarabine; Procedure: Multigated Acquisition Scan; Procedure: Pheresis; Procedure: Positron Emission Tomography Sponsors : Ohio State University Comprehensive Cancer Center Not yet recruiting"
importance: ""
sourceUrl: "https://clinicaltrials.gov/study/NCT07166419?term=interventional+radiology&aggFilters=status%3A"
tags: ["France", "Actualité", "ClinicalTrials.gov — ta recherche"]
permalink: "/papers/2025-09-10-anti-cd192022-chimeric-antigen-receptor-t-cells-tricar192022-t-cells-for-the-treatment-of-relapsed-or-refractory-non-hodgkin-lymphoma-acute-lymphoblastic-leukemia-and-chronic-lymphocytic-leukemia"
imageUrl: ""
imageCredit: ""
---

## L’essentiel

Conditions : Blast Phase Chronic Myeloid Leukemia, BCR-ABL1 Positive; Recurrent Acute Lymphoblastic Leukemia; Recurrent Chronic Lymphocytic Leukemia; Recurrent Chronic Myeloid Leukemia, BCR-ABL1 Positive; Recurrent Indolent Non-Hodgkin Lymphoma; Recurrent Lymphoblastic Lymphoma; Recurrent Non-Hodgkin Lymphoma; Recurrent Transformed Chronic Lymphocytic Leukemia; Refractory Acute Lymphoblastic Leukemia; Refractory Chronic Lymphocytic Leukemia; Refractory Chronic Myeloid Leukemia, BCR-ABL1 Positive; Refractory Indolent Non-Hodgkin Lymphoma; Refractory Lymphoblastic Lymphoma; Refractory Non-Hodgkin Lymphoma; Refractory Transformed Chronic Lymphocytic Leukemia Interventions : Biological: Autologous Anti-CD19/CD20/CD22 CAR T-cells; Procedure: Biospecimen Collection; Procedure: Bone Marrow Aspiration; Procedure: Bone Marrow Biopsy; Procedure: Computed Tomography; Drug: Cyclophosphamide; Procedure: Echocardiography Test; Drug: Fludarabine; Procedure: Multigated Acquisition Scan; Procedure: Pheresis; Procedure: Positron Emission Tomography Sponsors : Ohio State University Comprehensive Cancer Center Not yet recruiting

## Lien source

https://clinicaltrials.gov/study/NCT07166419?term=interventional+radiology&aggFilters=status%3A
